© 2020 MJH Life Sciences and OncLive. All rights reserved.
October 23, 2019
Alexander E. Perl, MD, MS, discusses the challenges of using immunotherapy with antibody-drug conjugates, bispecific T-cell engagers, and CAR T-cell therapies in acute myeloid leukemia.
October 02, 2019
Alexander E. Perl, MD, MS, discusses how to assess what therapy is best for patients with acute myeloid leukemia.